Close

Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. GM
3. SPY
4. SHW
5. SPOT
6. AMZN
7. AAPL
8. NVDA
9. MTTR
10. MINN


Go back to Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials
Regeneron (NASDAQ: REGN) Delayed: 910.45 +10.29 (1.14%)
Previous Close $900.16    52 Week High $592.36 
Open $905.66    52 Week Low $325.35 
Day High $912.74    P/E 238.96 
Day Low $903.83    EPS $3.81 
Volume 134,634       

SANOFI (NASDAQ: SNY) Delayed: 47.78 +0.63 (1.34%)
Previous Close $47.15    52 Week High $44.76 
Open $47.07    52 Week Low $36.81 
Day High $48.38    P/E N/A 
Day Low $47.00    EPS $0.00 
Volume 978,561